NOBILE, MARIANO
 Distribuzione geografica
Continente #
AS - Asia 233
EU - Europa 116
NA - Nord America 92
SA - Sud America 12
AF - Africa 4
Totale 457
Nazione #
SG - Singapore 109
US - Stati Uniti d'America 88
RU - Federazione Russa 74
CN - Cina 71
IT - Italia 21
VN - Vietnam 15
HK - Hong Kong 13
BR - Brasile 12
KR - Corea 9
DE - Germania 8
IN - India 6
AT - Austria 3
FI - Finlandia 3
BD - Bangladesh 2
CI - Costa d'Avorio 2
GB - Regno Unito 2
MX - Messico 2
PL - Polonia 2
SA - Arabia Saudita 2
SE - Svezia 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
CA - Canada 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
NL - Olanda 1
NP - Nepal 1
PH - Filippine 1
TW - Taiwan 1
Totale 457
Città #
Singapore 55
Hefei 48
Ashburn 17
Moscow 16
Hong Kong 13
Beijing 9
Seoul 9
Ho Chi Minh City 8
Santa Clara 8
Naples 6
Los Angeles 5
Munich 5
Catania 3
Hanoi 3
Houston 3
New York 3
Treia 3
Boston 2
Buffalo 2
Dallas 2
Denver 2
Kochi 2
Mexico City 2
Rome 2
Warsaw 2
Afragola 1
Araçatuba 1
Atlanta 1
Baku 1
Belo Horizonte 1
Bhopal 1
Bismarck 1
Brooklyn 1
Chandler 1
Chennai 1
Chesapeake 1
Contagem 1
Da Nang 1
Dammam 1
East Saint Louis 1
Frankfurt am Main 1
Garibaldi 1
Helena 1
Helsinki 1
Itajaí 1
Jeddah 1
Kingston 1
Kozhikode 1
Kronberg 1
Ladson 1
Lappeenranta 1
Malmo 1
Mauá 1
Monte Alto 1
Montreal 1
Natal 1
Ninh Bình 1
Poplar 1
Port Elizabeth 1
Pune 1
Redondo Beach 1
San Fernando City 1
St Louis 1
Stockholm 1
São José dos Campos 1
São Paulo 1
Tampa 1
Thành Phố Bà Rịa 1
Tokyo 1
Turku 1
Tây Ninh 1
Ubirajara 1
Valparaíso de Goiás 1
Vienna 1
Wiedergeltingen 1
Totale 280
Nome #
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 103
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series 95
Outpatient Use of Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Mild-to-Moderate Coronavirus Disease 2019 94
Effectiveness and Tolerability of Early Treatment with Monoclonal Antibodies against SARS-Cov-2: Results from A Real-Life Study before Omicron Surge 86
Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused 84
Totale 462
Categoria #
all - tutte 1.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 0 3 0 2 3 0 2 0
2023/202421 1 4 3 3 1 1 0 4 0 0 4 0
2024/2025166 5 2 0 1 5 13 18 13 7 14 69 19
2025/2026265 39 55 55 42 59 15 0 0 0 0 0 0
Totale 462